Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Knockdown of Ki-67 by dicer-substrate small interfering RNA sensitizes bladder cancer cells to curcumin-induced tumor inhibition.

Pichu S, Krishnamoorthy S, Shishkov A, Zhang B, McCue P, Ponnappa BC.

PLoS One. 2012;7(11):e48567. doi: 10.1371/journal.pone.0048567. Epub 2012 Nov 12.

2.

VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.

Zhu H, Yun F, Shi X, Wang D.

Mol Med Rep. 2015 Aug;12(2):3163-9. doi: 10.3892/mmr.2015.3684. Epub 2015 Apr 24.

PMID:
25936422
3.

Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.

Luo HB, Li B, Yuan WG, Xu CR.

J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):730-5. doi: 10.1007/s11596-015-1498-y. Epub 2015 Oct 22.

PMID:
26489630
4.

Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.

Saini S, Arora S, Majid S, Shahryari V, Chen Y, Deng G, Yamamura S, Ueno K, Dahiya R.

Cancer Prev Res (Phila). 2011 Oct;4(10):1698-709. doi: 10.1158/1940-6207.CAPR-11-0267. Epub 2011 Aug 11.

5.

HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.

Selvendiran K, Ahmed S, Dayton A, Kuppusamy ML, Rivera BK, Kálai T, Hideg K, Kuppusamy P.

Cancer Biol Ther. 2011 Nov 1;12(9):837-45. doi: 10.4161/cbt.12.9.17713. Epub 2011 Nov 1.

PMID:
21885917
6.

Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model.

Tian B, Wang Z, Zhao Y, Wang D, Li Y, Ma L, Li X, Li J, Xiao N, Tian J, Rodriguez R.

Cancer Lett. 2008 Jun 18;264(2):299-308. doi: 10.1016/j.canlet.2008.01.041. Epub 2008 Mar 14.

PMID:
18342436
8.

Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.

Han Y, Liu Y, Gui Y, Cai Z.

J Surg Oncol. 2013 Feb;107(2):201-5. doi: 10.1002/jso.23214. Epub 2012 Jul 5.

PMID:
22766726
9.

Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs.

Ke CS, Liu HS, Yen CH, Huang GC, Cheng HC, Huang CY, Su CL.

J Nutr Biochem. 2014 May;25(5):526-39. doi: 10.1016/j.jnutbio.2014.01.003. Epub 2014 Feb 5.

PMID:
24613085
10.

Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors.

Kamat AM, Tharakan ST, Sung B, Aggarwal BB.

Cancer Res. 2009 Dec 1;69(23):8958-66. doi: 10.1158/0008-5472.CAN-09-2045. Epub 2009 Nov 10.

11.

Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.

Ping SY, Wu CL, Yu DS.

Urol Oncol. 2012 Sep;30(5):652-9. doi: 10.1016/j.urolonc.2010.07.001. Epub 2010 Sep 29.

PMID:
20884251
12.

Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.

Zhao Z, Li C, Xi H, Gao Y, Xu D.

Mol Med Rep. 2015 Oct;12(4):5415-22. doi: 10.3892/mmr.2015.4060. Epub 2015 Jul 8.

PMID:
26166196
13.

Curcumin decreases specificity protein expression in bladder cancer cells.

Chadalapaka G, Jutooru I, Chintharlapalli S, Papineni S, Smith R 3rd, Li X, Safe S.

Cancer Res. 2008 Jul 1;68(13):5345-54. doi: 10.1158/0008-5472.CAN-07-6805.

14.

Curcumin-induced downregulation of Axl receptor tyrosine kinase inhibits cell proliferation and circumvents chemoresistance in non-small lung cancer cells.

Kim KC, Baek SH, Lee C.

Int J Oncol. 2015 Dec;47(6):2296-303. doi: 10.3892/ijo.2015.3216. Epub 2015 Oct 21.

PMID:
26498137
15.

Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells.

Huang YT, Cheng CC, Lin TC, Chiu TH, Lai PC.

Oncol Rep. 2014 Feb;31(2):771-80. doi: 10.3892/or.2013.2882. Epub 2013 Nov 28.

PMID:
24297644
16.

T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.

Liu H, Zhou BH, Qiu X, Wang HS, Zhang F, Fang R, Wang XF, Cai SH, Du J, Bu XZ.

Free Radic Biol Med. 2012 Dec 15;53(12):2204-17. doi: 10.1016/j.freeradbiomed.2012.10.537. Epub 2012 Oct 17.

PMID:
23085518
17.

Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.

Watson JL, Greenshields A, Hill R, Hilchie A, Lee PW, Giacomantonio CA, Hoskin DW.

Mol Carcinog. 2010 Jan;49(1):13-24. doi: 10.1002/mc.20571.

PMID:
19676105
18.

Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.

Metwalli AR, Khanbolooki S, Jinesh G, Sundi D, Shah JB, Shrader M, Choi W, Lashinger LM, Chunduru S, McConkey DJ, McKinlay M, Kamat AM.

Cancer Biol Ther. 2010 Nov 1;10(9):885-92. doi: 10.4161/cbt.10.9.13237. Epub 2010 Nov 1.

19.

Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.

Montopoli M, Ragazzi E, Froldi G, Caparrotta L.

Cell Prolif. 2009 Apr;42(2):195-206. doi: 10.1111/j.1365-2184.2009.00585.x. Epub 2009 Feb 18.

PMID:
19236381
20.

A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.

Altenburg JD, Bieberich AA, Terry C, Harvey KA, Vanhorn JF, Xu Z, Jo Davisson V, Siddiqui RA.

BMC Cancer. 2011 Apr 21;11:149. doi: 10.1186/1471-2407-11-149.

Supplemental Content

Support Center